CPI-0610, A BROMODOMAIN AND EXTRATERMINAL DOMAIN (BET) INHIBITOR, REDUCES PRO-INFLAMMATORY CYTOKINES, BONE MARROW FIBROSIS AND THE NUMBER OF TRANSFUSIONS IN MYELOFIBROSIS PATIENTS
EHA Library, Ronald Hoffman, 267414
TNF-Α BLOCKADE CORRECTS THE MONOCYTE/MACROPHAGE IMBALANCE IN PRIMARY IMMUNE THROMBOCYTOPENIA (ITP)
EHA Library, Yajing Zhao, 267432
A PHASE 2 OPEN-LABEL PROOF OF CONCEPT STUDY OF THE ORAL, SMALL MOLECULE FACTOR D INHIBITOR, ACH-4471, IN UNTREATED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
EHA Library, Peter Browett, 267447
PET AFTER 2 CYCLES OF ABVD IN PATIENTS WITH EARLY-STAGE FAVORABLE HODGKIN LYMPHOMA TREATED WITHIN THE PHASE 3 GHSG HD16 STUDY
EHA Library, Michael Fuchs, 267402
A PHASE 3 RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY OF ISATUXIMAB, POMALIDOMIDE, AND LOW-DOSE DEXAMETHASONE VS POMALIDOMIDE AND LOW-DOSE DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
EHA Library, Paul Richardson, 267407
SOTATERCEPT (ACE-011) IN SUBJECTS WITH MPN-ASSOCIATED MYELOFIBROSIS AND ANEMIA
EHA Library, Prithviraj Bose, 267412
PEGCRISANTASPASE AND VENETOCLAX COMBINATION IS HIGHLY EFFECTIVE AGAINST ACUTE MYELOID LEUKEMIA (AML), MECHANISTICALLY DRIVEN SYNERGISM BETWEEN GLUTAMINE DEPLETION AND BCL-2 INHIBITION
EHA Library, Ashkan Emadi, 267417
TRANSFUSION DEPENDENCY IS ASSOCIATED WITH PRESENCE OF TOXIC IRON SPECIES AND INFERIOR SURVIVAL IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES
EHA Library, Marlijn Hoeks, 267421
THE PROLIFERATIVE HISTORY SHAPES THE DNA METHYLOME OF B-CELL TUMORS AND PREDICTS CLINICAL OUTCOME
EHA Library, Martí Duran-Ferrer, 267426
ALLELIC POLYMORPHISM OF PLATELET GLYCOPROTEIN GENES GPIA AND GPIIB AS A POSSIBLE PREDICTIVE MARKER OF RESPONSE TO THERAPY IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA
EHA Library, Irina Zotova, 267431
SUCCESSOR: A MULTICENTER RETROSPECTIVE NONINTERVENTIONAL FOLLOW-UP STUDY IN PATIENTS WITH SICKLE CELL PAIN CRISES WHO PREVIOUSLY PARTICIPATED IN THE SUSTAIN TRIAL IN THE UNITED STATES
EHA Library, Darla Liles, 267436
SUZ12 INACTIVATION COOPERATES WITH JAK3 MUTANT SIGNALING TO DRIVE T-ALL DEVELOPMENT
EHA Library, Michael Broux, 267441
THE ROLE OF GATA2 IN HSC GENERATION THROUGH ENDOTHELIAL-TO-HEMATOPOIETIC TRANSITION.
EHA Library, Cansu Koyunlar, 267445
PRIMARY THERAPY AND SURVIVAL AMONG ADULT PATIENTS WITH NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA (NLPHL): A POPULATION-BASED ANALYSIS IN THE NETHERLANDS, 1993-2016
EHA Library, Hidde Posthuma, 267401
RANDOMIZED, OPEN-LABEL, NON-INFERIORITY, PHASE 3 STUDY OF SUBCUTANEOUS (SC) VERSUS INTRAVENOUS (IV) DARATUMUMAB (DARA) ADMINISTRATION IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: COLUMBA
EHA Library, María-Victoria Mateos, 267406
A RANDOMIZED, DOUBLE BLIND PHASE 2 STUDY OF 3 DIFFERENT DOSES OF PRM-151 IN PATIENTS WITH MYELOFIBROSIS WHO WERE PREVIOUSLY TREATED WITH OR INELIGIBLE FOR RUXOLITINIB
EHA Library, Srdan Verstovsek, 267411
THE SINGLE-CELL ATLAS OF DRIVER MUTATIONS IN AML
EHA Library, Kiyomi Morita, 267416
TREATMENT WITH IMETELSTAT PROVIDES DURABLE TRANSFUSION INDEPENDENCE (TI) IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER RISK MDS (LR-MDS) RELAPSED/REFRACTORY (R/R) TO ERYTHROPOIESIS STIMULATING AGENTS (ESAS)
EHA Library, Pierre Fenaux, 267420
MODELING MANTLE CELL LYMPHOMA IN MICE
EHA Library, Tim Pieters, 267425
DISTINCT AND COMMON DEREGULATED PATHWAYS IN RUNX1, GATA1 AND GFI1B ASSOCIATED BLEEDING DISORDERS
EHA Library, Maaike van Bergen, 267430
IN VIVO SELECTION FOR CORRECTED BETA-GLOBIN ALLELES AFTER CRISPR/CAS9 EDITING IN HUMAN SICKLE HEMATOPOIETIC STEM CELLS ENHANCES THERAPEUTIC POTENTIAL
EHA Library, Mark WALTERS, 267435
THE NUCLEOTIDE KINASE NADK CONSTITUTES A METABOLIC VULNERABILITY OF NOTCH1-DRIVEN T-ALL
EHA Library, Etienne De Braekeleer, 267440
LOSS OF THE F-BOX PROTEIN NIPA CAUSES BONE MARROW FAILURE
EHA Library, Stefanie Kreutmair, 267444
Somatic mutations in aplastic anemia: Significance for classification, therapy, and outcome
EHA Library, Judith Marsh, 273661
Immunosuppression and stem cell stimulation to treat AA: Clinical and biologic implications
EHA Library, Neal Young, 273662
Stem cell transplantation in aplastic anemia: Impact on choices for first line therapy
EHA Library, Andrea Bacigalupo, 273663
The diagnostic potential of the iron regulatory hormone hepcidin
EHA Library, Andrew Armitage, 273688
Mechanisms, mishaps and manipulation of iron uptake
EHA Library, Sant-Ryan Pasricha, 273689
Novel approaches to oral iron treatment
EHA Library, Diego Moretti, 273690
Bone marrow niche in multiple myeloma and its precursor states
EHA Library, Irene Ghobrial, 273694
Minimal residual disease (MRD) in multiple myeloma: Prognostic and therapeutic implications (including imaging)
EHA Library, Roger Owen, 273695
Front-line treatment of multiple myeloma
EHA Library, Michele Cavo, 273696
Mechanisms of cancer-associated thrombosis
EHA Library, Christophe Dubois, 273664
Screening for cancer in unprovoked venous thromboembolism
EHA Library, Marc Carrier, 273665
Direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer
EHA Library, Guy Meyer, 273666
Genetic predisposition to chronic lymphocytic leukemia
EHA Library, Richard Houlston, 273670
Mechanisms of resistance to targeted therapies in chronic lymphocytic leukemia
EHA Library, Lesley-Ann Sutton, 273671
Combining novel agents in chronic lymphocytic leukemia: Greater than the sum of its parts?
EHA Library, Arnon Kater, 273672
Medical management of acute responses to radiation
EHA Library, Nelson Chao, 273706
Microbiota and GvHD: A double edged sword
EHA Library, Ernst Holler, 273707
Unmanipulated Haploidentical transplantation for adult patients with hematological malignancies
EHA Library, Annalisa Ruggeri, 273708
RAS/MAPK ACTIVATION COOPERATES WITH GAIN OF CHROMOSOME 21 IN B CELL LEUKEMIA AND IS AN ATTRACTIVE TARGET TO IMPROVE THE OUTCOME OF DS CHILDREN WITH B-ALL
EHA Library, Anouchka Laurent, 265941
XBP1 PROMOTES PRE-B CELL ACUTE LYMPHOBLASTIC LEUKEMIA THROUGH OF IL-7 RECEPTOR SIGNALING IN MICE
EHA Library, Azam Salimi, 265942
KINASE AND CYTOKINE RECEPTOR SIGNALING PATHWAY ACTIVATING ALTERATIONS IN UNIFORMLY TREATED B-ALL
EHA Library, Rimvydas Norvilas, 265958
LONG-TERM INHIBITION OF CHK1/CHK2 KINASES MODIFY ACUTE LYMPHOBLASTIC LEUKEMIA CELL LINE RESPONSE TO DNA DAMAGING AGENTS
EHA Library, Andrea Ghelli Luserna di Rora, 265959
EFFICACY OF CONSOLIDATION CHEMOTHERAPY FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA WHO ACHIEVED COMPLETE REMISSION BY FIRST COURSE OF REMISSION INDUCTION THERAPY.
EHA Library, Akio Shigematsu, 265974
WT1 OVEREXPRESSION PREDICTED GOOD OUTCOMES IN ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS RECEIVING CHEMOTHERAPY
EHA Library, Shu-Juan Wang, 265975
CARBENOXOLONE REVERSES MICROENVIRONMENT-INDUCED CHEMORESISTANCE OF ACUTE MYELOID LEUKEMIA
EHA Library, Farah KOUZI, 265990
THE COMBINATION OF IMGN632, A CD123-TARGETING ADC, WITH VENETOCLAX ENHANCES ANTI-LEUKEMIC ACTIVITY IN VITRO AND PROLONGS SURVIVAL IN VIVO IN PRE-CLINICAL MODELS OF HUMAN AML
EHA Library, Sharlene Adams, 265991
ROLE OF MEASURABLE RESIDUAL DISEASE (MRD) IN REDEFINING COMPLETE RESPONSE (CR) IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): RESULTS FROM THE PETHEMA-FLUGAZA PHASE III CLINICAL TRIAL
EHA Library, Pau Montesinos, 266006
TARGETING FLT3 IN AML: MODULATION OF FLT3-BITE® ACTIVITY THROUGH COMBINATION WITH VARIOUS TKI
EHA Library, Bettina Brauchle, 266007
PROGNOSTIC IMPACT OF THE 2017 EUROPEAN LEUKEMIANET (ELN) CLASSIFICATION OF YOUNGER ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) TREATED ON CANCER AND LEUKEMIA GROUP B (CALGB)/ALLIANCE PROTOCOLS
EHA Library, Marius Bill, 266022
SIGNIFICANT REDUCTION OF REGULATORY INNATE LYMPHOID CELLS (ILCREGS, CD45+LIN-CD127+IL-10+) AND CD45+LIN-CD127+IL-10- CELLS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA DETECTED BY FLOW CYTOMETRY
EHA Library, Jifeng Yu, 266024
NEXT-GENERATION-SEQUENCE-BASED GENE MUTATION DETECTION AND ITS CLINICAL SIGNIFICANCE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA.
EHA Library, Jifeng Yu, 266047
HNRNP K OVEREXPRESSION INDUCE NUCLEOLAR STRESS, A HALLMARK OF ACUTE MYELOID LEUKEMIA
EHA Library, Pedro Aguilar-Garrido, 266049
COMBINING FLOW CYTOMETRY-BASED LEUKEMIC CELL ENRICHMENT AND MUTATIONAL ANALYSIS FOR DETECTION OF RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA: A PILOT STUDY
EHA Library, Albert Wölfler, 266066
RISK ASSESSMENT OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH ACUTE LEUKEMIA AND CONCOMITANT ISCHEMIC HEART DISEASE
EHA Library, Tetiana Lymanets, 266067
THE EFFECT OF MODERN THERAPEUTICS IN ADULT ACUTE MYELOID LEUKEMIA (AML): POPULATION-BASED ANALYSIS OF LONG-TERM OUTCOMES FROM THE MANITOBA CANCER REGISTRY
EHA Library, Laura Tapley, 266082
A RETROSPECTIVE STUDY OF MYELOID LEUKAEMIA IN CHILDREN WITH DOWN SYNDROME IN IRELAND
EHA Library, Gavin Dowling, 266083
LISOCABTAGENE MARALEUCEL TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA AND SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA: INITIAL RESULTS FROM TRANSCEND NHL 001
EHA Library, Jeremy Abramson, 266098
EARLY RESPONSE OBSERVATION OF PEDIATRIC PATIENTS WITH BURKITT'S LYMPHOMA TREATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS
EHA Library, J Pan, 266099
REAL WORLD CLINICAL EFFECTIVENESS AND SAFETY OF CT-P10 IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: INTERIM RESULTS FROM A EUROPEAN NON-INTERVENTIONAL POST-AUTHORISATION SAFETY STUDY
EHA Library, Pier Luigi Zinzani, 266114
CLINICAL VALUE OF DIFFUSION-WEIGHTED WHOLE-BODY IMAGING WITH BACKGROUND BODY SIGNAL SUPPRESSION IN NEWLY DIAGNOSED LYMPHOMA PATIENTS
EHA Library, Haiwen Huang, 266115
MODE OF DELIVERY IN NEWBORNS WITH HEMOPHILIA: ASSOCIATION WITH FAMILY HISTORY/MATERNAL CARRIER STATUS, SEVERITY OF HEMOPHILIA AND INCIDENCE OF INTRACRANIAL/EXTRACRANIAL HEMORRHAGE
EHA Library, Aikaterini MICHALOPOULOU, 266130
COST-EFFECTIVENESS OF EMICIZUMAB VERSUS BY-PASSING AGENTS IN PATIENTS WITH HAEMOPHILIA A AND FVIII INHIBITORS IN FRANCE
EHA Library, Benoit Polack, 266131
ZEBRAFISH AS A NOVEL MODEL TO STUDY GATA2 HAPLOINSUFFICIENCY SYNDROMES
EHA Library, Emanuele gioacchino, 266146
PHARMACOKINETIC AND PHARMACODYNAMIC SIMILARITY OF ABP 959 WITH ECULIZUMAB: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, SINGLE-DOSE, PARALLEL-GROUP STUDY IN HEALTHY SUBJECTS
EHA Library, Vincent Chow, 266147
A FIRST HIGH-DEFINITION LANDSCAPE OF SOMATIC MUTATIONS IN CHRONIC LYMPHOPROLIFERATIVE DISORDER OF NK CELLS
EHA Library, Vanessa Rebecca Gasparini, 266162
UNDETECTABLE EXPRESSION OF WNT5A, A GENE ENCODING A ROR1 LIGAND, DEFINES MEMORY B-CELL LIKE CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Lucie Poppova, 266163
TREATMENT EMERGENT ADVERSE EVENTS VARY WITH DIFFERENT PI3K INHIBITORS
EHA Library, Farrukh Awan, 266178
PREVALENCE AND INCIDENCE OF CARDIOVASCULAR DISEASE IN CHRONIC LYMPHOCYTIC LEUKEMIA: A NATION-WIDE POPULATION-BASED STUDY.
EHA Library, Karin Larsson, 266179
RHYTHM AND CONDUCTION DISORDERS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING TREATMENT WITH IBRUTINIB.
EHA Library, Elena EMELINA, 266194
COMPLEX EVALUATION OF CELLULAR AND HUMORAL IMMUNITY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Lukáš Smolej, 266195
DOUBLING TIME AFTER FIRST ATTEMPT OF IMATINIB DISCONTINUATION IS HELPFUL TO IDENTIFY THE BEST CANDIDATE FOR THE SECOND ATTEMPT FOR TREATMENT-FREE REMISSION WITH DASATINIB: CANADIAN TRAD TRIAL
EHA Library, Dennis KIM, 266210
ENESTOP 192-WK RESULTS: DURABILITY AND IMPACT ON QUALITY OF LIFE OF TREATMENT-FREE REMISSION (TFR) FOLLOWING SECOND-LINE (2L) NILOTINIB (NIL) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA (CML)
EHA Library, Francois-Xavier Mahon, 266211
GENOTYPE-RESPONSE CORRELATION IN DRIVE PK, A PHASE 2 STUDY OF MITAPIVAT (AG-348) IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY
EHA Library, Charles Kung, 266226
TREATMENT WITH 5-AZACYTIDINE RESULTS IN EXPRESSION OF LONG TERMINAL REPEAT (LTR) ELEMENTS IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH MDS AND AML: FIRST PILOT STUDY.
EHA Library, Michael Daskalakis, 266242
THIOPURINE-MEDIATED IMPAIRMENT OF HEMATOPOIEIC STEM AND PROGENITOR CELLS IN NUDT15R138C KNOCK-IN MICE AND POTENTIALITY OF NUDT15 GENOTYPE-BASED PRECISION MEDICINE FOR ACUTE LEUKEMIA
EHA Library, Goichi Tatsumi, 266258
RETROSPECTIVE REAL-LIFE STUDY OF BRENTUXIMAB VEDOTIN IN ASSOCIATION WITH BENDAMUSTINE IN REFRACTORY OR MULTIPLE RELAPSED HODGKIN LYMPHOMA.
EHA Library, Emilio iannitto, 266274
PRESENCE OF BRAFV600E MUTATION IN CHILDHOOD LCH CORRELATES WITH MULTISYSTEM DISEASE AND A POOR SURVIVAL
EHA Library, Prateek Bhatia, 266290
EVIDENCE FOR AN ALTERNATIVE MECHANISM SUPPRESSING HEPCIDIN DURING THE RECOVERY FROM HEMORRHAGE-INDUCED ANEMIA
EHA Library, Ugo Sardo, 266306
EVALUATION OF SERINE BIOSYNTHESIS PATHWAY AS A POTENTIAL THERAPEUTIC TARGET IN BURKITT LYMPHOMA
EHA Library, Emilia Bialopiotrowicz, 266324
TERT PROMOTER METHYLATION AS A POTENTIAL PROGNOSTIC BIOMARKER FOR PROGRESSION OF UNEXPLAINED CYTOPENIA TO MDS AND AML
EHA Library, Katja Kaastrup, 266340
PRECLINICAL EVALUATION OF THE NEW GPRC5DXCD3 (JNJ-7564) BISPECIFIC ANTIBODY FOR THE TREATMENT OF MULTIPLE MYELOMA
EHA Library, Christie Verkleij, 266356
TARGETED ULTRA-DEEP NGS ASSESSMENT OF TP53 MUTATIONS IN MULTIPLE MYELOMA FROM WHOLE BONE MARROW
EHA Library, Anna PETRACKOVA, 266373
MONITORING THE CYTOGENETIC ARCHITECTURE OF MINIMAL RESIDUAL PLASMA CELLS INDICATES THE THERAPY-INDUCED CLONAL SELECTION IN MULTIPLE MYELOMA.
EHA Library, Yuting Yan, 266389
ADVERSE IMPACT OF PRIOR THERAPY ON TRANSPLANT OUTCOME IN MULTIPLE MYELOMA
EHA Library, Amani Erra, 266405
CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA
EHA Library, Claudio CERCHIONE, 266421
IMMUNE ELECTRON MICROSCOPY AND MASS SPECTROMETRY FOR CLASSIFICATION OF AMYLOID DEPOSITS
EHA Library, Niels Abildgaard, 266438
PROGNOSTIC RELEVANCE OF THE GENE EXPRESSION SIGNATURE IN PRIMARY AND SECONDARY MYELOFIBROSIS
EHA Library, Sebastiano Rontauroli, 266454
RATE OF THROMBOSIS IN CONTEMPORARY PATIENTS WITH POLYCYTHEMIA VERA UNDER HYDROXYUREA REMAINS EXCEEDINGLY HIGH. RESULTS OF SYSTEMATIC REVIEW AND METANALYSIS.
EHA Library, Alberto Ferrari, 266470
RISK OF THROMBOSIS IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA ACCORDING TO THE JAK2 V617F ALLELE BURDEN
EHA Library, Sung Hwa Bae, 266486
LONG-TERM FOSTAMATINIB TREATMENT OF ADULTS WITH IMMUNE THROMBOCYTOPENIA (ITP) DURING THE PHASE 3 CLINICAL TRIAL PROGRAM
EHA Library, J Bussel, 266502
CLINICAL OUTCOMES OF SOLID ORGAN TRANSPLANT PATIENTS WITH EBV+PTLD WHO FAIL FIRST-LINE RITUXIMAB OR RITUXIMAB PLUS CHEMOTHERAPY: AN ANALYSIS OF GERMAN PTLD REGISTRY
EHA Library, Heiner Zimmermann, 266518
ECONOMIC MODEL TO EVALUATE THE COST-EFFECTIVENESS OF SECOND-LINE NILOTINIB VERSUS DASATINIB FOR THE TREATMENT OF PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKEMIA (CML-CP) IN GERMANY
EHA Library, Ricardo Viana, 266534
POST-TRANSPLANT CYCLOPHOSPHAMIDE AND SIROLIMUS IN HAPLOIDENTICAL TRANSPLANT WITH PBSC GRAFTS: RESULTS IN 151 PATIENTS
EHA Library, Margherita Silani, 266550
PHASE 2 STUDY EVALUATING THE SAFETY AND EFFICACY OF ONE OR TWO DOSES OF DONOR LYMPHOCYTES DEPLETED OF HOST ALLOREACTIVE T-CELLS (ATIR101) FOLLOWING T-CELL-DEPLETED HAPLOIDENTICAL HSCT
EHA Library, Eduardo Olavarria, 266566
TREG DOWNREGULATION IS ASSOCIATED WITH INCREASE OF T CELL RESPONSES AGAINST IMMUNOGENIC ANTIGENS AND CLINICAL RESPONSES IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER DONOR LYMPHOCYTE INFUSION
EHA Library, Jochen GREINER, 266582
SULFATED NON-ANTICOAGULANT LOW MOLECULAR WEIGHT HEPARIN (S-NACH) IN COMBATING CANCER ASSOCIATED THROMBOSIS WITHOUT EFFECTS ON HEMOSTASIS
EHA Library, Shaker Mousa, 266599
DEFORMABILITY OF PACKED RED BLOOD CELLS: UNIT-TO-UNIT VARIABILITY.
EHA Library, Gregory Barshtein, 266615

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings